In the past few months, there’s been a lot of buzz in the NET community about histotripsy. This newly approved procedure holds a lot of promise for treating NETs, and may prove to be even more exciting in the future. In this episode of NETwise, we’re telling you everything we know about this new treatment: how it works, how it came to be, and what it means for NET patients.
To download a copy of the transcript for this episode: netrf.org/podcast/netwise-epi...
To listen to other NETWise episodes: netrf.org/podcast/
NETWise is a podcast featuring neuroendocrine cancer experts and patients, produced by the Neuroendocrine Tumor Research Foundation (NETRF) in Boston, MA, USA.
17 май 2024
